Global Translational Regenerative Medicine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 100

Published Date: 07 Jan 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Translational Regenerative Medicine market size was valued at USD 12590 million in 2022 and is forecast to a readjusted size of USD 29460 million by 2029 with a CAGR of 12.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Translational Regenerative Medicine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Translational Regenerative Medicine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Translational Regenerative Medicine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Translational Regenerative Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Translational Regenerative Medicine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Translational Regenerative Medicine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Translational Regenerative Medicine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Athersys, Avita Medical, AxoGen, MEDIPOST and NuVasive, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Translational Regenerative Medicine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Stem Cell Therapy
    Tissue Engineering
    Gene Therapy

Market segment by Application
    Tissue Engineering Therapy
    Wound Healing
    Cartilage Repair
    Other

Major players covered
    Athersys
    Avita Medical
    AxoGen
    MEDIPOST
    NuVasive
    Astellas Pharma
    Organogenesis Holdings
    Osiris Therapeutics
    Pharmicell
    Regenerys
    Takeda Pharmaceutical
    uniQure
    Vericel

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Translational Regenerative Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Translational Regenerative Medicine, with price, sales, revenue and global market share of Translational Regenerative Medicine from 2018 to 2023.
Chapter 3, the Translational Regenerative Medicine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Translational Regenerative Medicine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Translational Regenerative Medicine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Translational Regenerative Medicine.
Chapter 14 and 15, to describe Translational Regenerative Medicine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Translational Regenerative Medicine
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Translational Regenerative Medicine Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Stem Cell Therapy
        1.3.3 Tissue Engineering
        1.3.4 Gene Therapy
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Translational Regenerative Medicine Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Tissue Engineering Therapy
        1.4.3 Wound Healing
        1.4.4 Cartilage Repair
        1.4.5 Other
    1.5 Global Translational Regenerative Medicine Market Size & Forecast
        1.5.1 Global Translational Regenerative Medicine Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Translational Regenerative Medicine Sales Quantity (2018-2029)
        1.5.3 Global Translational Regenerative Medicine Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Athersys
        2.1.1 Athersys Details
        2.1.2 Athersys Major Business
        2.1.3 Athersys Translational Regenerative Medicine Product and Services
        2.1.4 Athersys Translational Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Athersys Recent Developments/Updates
    2.2 Avita Medical
        2.2.1 Avita Medical Details
        2.2.2 Avita Medical Major Business
        2.2.3 Avita Medical Translational Regenerative Medicine Product and Services
        2.2.4 Avita Medical Translational Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Avita Medical Recent Developments/Updates
    2.3 AxoGen
        2.3.1 AxoGen Details
        2.3.2 AxoGen Major Business
        2.3.3 AxoGen Translational Regenerative Medicine Product and Services
        2.3.4 AxoGen Translational Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 AxoGen Recent Developments/Updates
    2.4 MEDIPOST
        2.4.1 MEDIPOST Details
        2.4.2 MEDIPOST Major Business
        2.4.3 MEDIPOST Translational Regenerative Medicine Product and Services
        2.4.4 MEDIPOST Translational Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 MEDIPOST Recent Developments/Updates
    2.5 NuVasive
        2.5.1 NuVasive Details
        2.5.2 NuVasive Major Business
        2.5.3 NuVasive Translational Regenerative Medicine Product and Services
        2.5.4 NuVasive Translational Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 NuVasive Recent Developments/Updates
    2.6 Astellas Pharma
        2.6.1 Astellas Pharma Details
        2.6.2 Astellas Pharma Major Business
        2.6.3 Astellas Pharma Translational Regenerative Medicine Product and Services
        2.6.4 Astellas Pharma Translational Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Astellas Pharma Recent Developments/Updates
    2.7 Organogenesis Holdings
        2.7.1 Organogenesis Holdings Details
        2.7.2 Organogenesis Holdings Major Business
        2.7.3 Organogenesis Holdings Translational Regenerative Medicine Product and Services
        2.7.4 Organogenesis Holdings Translational Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Organogenesis Holdings Recent Developments/Updates
    2.8 Osiris Therapeutics
        2.8.1 Osiris Therapeutics Details
        2.8.2 Osiris Therapeutics Major Business
        2.8.3 Osiris Therapeutics Translational Regenerative Medicine Product and Services
        2.8.4 Osiris Therapeutics Translational Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Osiris Therapeutics Recent Developments/Updates
    2.9 Pharmicell
        2.9.1 Pharmicell Details
        2.9.2 Pharmicell Major Business
        2.9.3 Pharmicell Translational Regenerative Medicine Product and Services
        2.9.4 Pharmicell Translational Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Pharmicell Recent Developments/Updates
    2.10 Regenerys
        2.10.1 Regenerys Details
        2.10.2 Regenerys Major Business
        2.10.3 Regenerys Translational Regenerative Medicine Product and Services
        2.10.4 Regenerys Translational Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Regenerys Recent Developments/Updates
    2.11 Takeda Pharmaceutical
        2.11.1 Takeda Pharmaceutical Details
        2.11.2 Takeda Pharmaceutical Major Business
        2.11.3 Takeda Pharmaceutical Translational Regenerative Medicine Product and Services
        2.11.4 Takeda Pharmaceutical Translational Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Takeda Pharmaceutical Recent Developments/Updates
    2.12 uniQure
        2.12.1 uniQure Details
        2.12.2 uniQure Major Business
        2.12.3 uniQure Translational Regenerative Medicine Product and Services
        2.12.4 uniQure Translational Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 uniQure Recent Developments/Updates
    2.13 Vericel
        2.13.1 Vericel Details
        2.13.2 Vericel Major Business
        2.13.3 Vericel Translational Regenerative Medicine Product and Services
        2.13.4 Vericel Translational Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Vericel Recent Developments/Updates

3 Competitive Environment: Translational Regenerative Medicine by Manufacturer
    3.1 Global Translational Regenerative Medicine Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Translational Regenerative Medicine Revenue by Manufacturer (2018-2023)
    3.3 Global Translational Regenerative Medicine Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Translational Regenerative Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Translational Regenerative Medicine Manufacturer Market Share in 2022
        3.4.2 Top 6 Translational Regenerative Medicine Manufacturer Market Share in 2022
    3.5 Translational Regenerative Medicine Market: Overall Company Footprint Analysis
        3.5.1 Translational Regenerative Medicine Market: Region Footprint
        3.5.2 Translational Regenerative Medicine Market: Company Product Type Footprint
        3.5.3 Translational Regenerative Medicine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Translational Regenerative Medicine Market Size by Region
        4.1.1 Global Translational Regenerative Medicine Sales Quantity by Region (2018-2029)
        4.1.2 Global Translational Regenerative Medicine Consumption Value by Region (2018-2029)
        4.1.3 Global Translational Regenerative Medicine Average Price by Region (2018-2029)
    4.2 North America Translational Regenerative Medicine Consumption Value (2018-2029)
    4.3 Europe Translational Regenerative Medicine Consumption Value (2018-2029)
    4.4 Asia-Pacific Translational Regenerative Medicine Consumption Value (2018-2029)
    4.5 South America Translational Regenerative Medicine Consumption Value (2018-2029)
    4.6 Middle East and Africa Translational Regenerative Medicine Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Translational Regenerative Medicine Sales Quantity by Type (2018-2029)
    5.2 Global Translational Regenerative Medicine Consumption Value by Type (2018-2029)
    5.3 Global Translational Regenerative Medicine Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Translational Regenerative Medicine Sales Quantity by Application (2018-2029)
    6.2 Global Translational Regenerative Medicine Consumption Value by Application (2018-2029)
    6.3 Global Translational Regenerative Medicine Average Price by Application (2018-2029)

7 North America
    7.1 North America Translational Regenerative Medicine Sales Quantity by Type (2018-2029)
    7.2 North America Translational Regenerative Medicine Sales Quantity by Application (2018-2029)
    7.3 North America Translational Regenerative Medicine Market Size by Country
        7.3.1 North America Translational Regenerative Medicine Sales Quantity by Country (2018-2029)
        7.3.2 North America Translational Regenerative Medicine Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Translational Regenerative Medicine Sales Quantity by Type (2018-2029)
    8.2 Europe Translational Regenerative Medicine Sales Quantity by Application (2018-2029)
    8.3 Europe Translational Regenerative Medicine Market Size by Country
        8.3.1 Europe Translational Regenerative Medicine Sales Quantity by Country (2018-2029)
        8.3.2 Europe Translational Regenerative Medicine Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Translational Regenerative Medicine Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Translational Regenerative Medicine Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Translational Regenerative Medicine Market Size by Region
        9.3.1 Asia-Pacific Translational Regenerative Medicine Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Translational Regenerative Medicine Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Translational Regenerative Medicine Sales Quantity by Type (2018-2029)
    10.2 South America Translational Regenerative Medicine Sales Quantity by Application (2018-2029)
    10.3 South America Translational Regenerative Medicine Market Size by Country
        10.3.1 South America Translational Regenerative Medicine Sales Quantity by Country (2018-2029)
        10.3.2 South America Translational Regenerative Medicine Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Translational Regenerative Medicine Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Translational Regenerative Medicine Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Translational Regenerative Medicine Market Size by Country
        11.3.1 Middle East & Africa Translational Regenerative Medicine Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Translational Regenerative Medicine Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Translational Regenerative Medicine Market Drivers
    12.2 Translational Regenerative Medicine Market Restraints
    12.3 Translational Regenerative Medicine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Translational Regenerative Medicine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Translational Regenerative Medicine
    13.3 Translational Regenerative Medicine Production Process
    13.4 Translational Regenerative Medicine Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Translational Regenerative Medicine Typical Distributors
    14.3 Translational Regenerative Medicine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Translational Regenerative Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Translational Regenerative Medicine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Athersys Basic Information, Manufacturing Base and Competitors
    Table 4. Athersys Major Business
    Table 5. Athersys Translational Regenerative Medicine Product and Services
    Table 6. Athersys Translational Regenerative Medicine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Athersys Recent Developments/Updates
    Table 8. Avita Medical Basic Information, Manufacturing Base and Competitors
    Table 9. Avita Medical Major Business
    Table 10. Avita Medical Translational Regenerative Medicine Product and Services
    Table 11. Avita Medical Translational Regenerative Medicine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Avita Medical Recent Developments/Updates
    Table 13. AxoGen Basic Information, Manufacturing Base and Competitors
    Table 14. AxoGen Major Business
    Table 15. AxoGen Translational Regenerative Medicine Product and Services
    Table 16. AxoGen Translational Regenerative Medicine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. AxoGen Recent Developments/Updates
    Table 18. MEDIPOST Basic Information, Manufacturing Base and Competitors
    Table 19. MEDIPOST Major Business
    Table 20. MEDIPOST Translational Regenerative Medicine Product and Services
    Table 21. MEDIPOST Translational Regenerative Medicine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. MEDIPOST Recent Developments/Updates
    Table 23. NuVasive Basic Information, Manufacturing Base and Competitors
    Table 24. NuVasive Major Business
    Table 25. NuVasive Translational Regenerative Medicine Product and Services
    Table 26. NuVasive Translational Regenerative Medicine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. NuVasive Recent Developments/Updates
    Table 28. Astellas Pharma Basic Information, Manufacturing Base and Competitors
    Table 29. Astellas Pharma Major Business
    Table 30. Astellas Pharma Translational Regenerative Medicine Product and Services
    Table 31. Astellas Pharma Translational Regenerative Medicine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Astellas Pharma Recent Developments/Updates
    Table 33. Organogenesis Holdings Basic Information, Manufacturing Base and Competitors
    Table 34. Organogenesis Holdings Major Business
    Table 35. Organogenesis Holdings Translational Regenerative Medicine Product and Services
    Table 36. Organogenesis Holdings Translational Regenerative Medicine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Organogenesis Holdings Recent Developments/Updates
    Table 38. Osiris Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 39. Osiris Therapeutics Major Business
    Table 40. Osiris Therapeutics Translational Regenerative Medicine Product and Services
    Table 41. Osiris Therapeutics Translational Regenerative Medicine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Osiris Therapeutics Recent Developments/Updates
    Table 43. Pharmicell Basic Information, Manufacturing Base and Competitors
    Table 44. Pharmicell Major Business
    Table 45. Pharmicell Translational Regenerative Medicine Product and Services
    Table 46. Pharmicell Translational Regenerative Medicine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Pharmicell Recent Developments/Updates
    Table 48. Regenerys Basic Information, Manufacturing Base and Competitors
    Table 49. Regenerys Major Business
    Table 50. Regenerys Translational Regenerative Medicine Product and Services
    Table 51. Regenerys Translational Regenerative Medicine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Regenerys Recent Developments/Updates
    Table 53. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 54. Takeda Pharmaceutical Major Business
    Table 55. Takeda Pharmaceutical Translational Regenerative Medicine Product and Services
    Table 56. Takeda Pharmaceutical Translational Regenerative Medicine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. Takeda Pharmaceutical Recent Developments/Updates
    Table 58. uniQure Basic Information, Manufacturing Base and Competitors
    Table 59. uniQure Major Business
    Table 60. uniQure Translational Regenerative Medicine Product and Services
    Table 61. uniQure Translational Regenerative Medicine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 62. uniQure Recent Developments/Updates
    Table 63. Vericel Basic Information, Manufacturing Base and Competitors
    Table 64. Vericel Major Business
    Table 65. Vericel Translational Regenerative Medicine Product and Services
    Table 66. Vericel Translational Regenerative Medicine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 67. Vericel Recent Developments/Updates
    Table 68. Global Translational Regenerative Medicine Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 69. Global Translational Regenerative Medicine Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 70. Global Translational Regenerative Medicine Average Price by Manufacturer (2018-2023) & (USD/Unit)
    Table 71. Market Position of Manufacturers in Translational Regenerative Medicine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 72. Head Office and Translational Regenerative Medicine Production Site of Key Manufacturer
    Table 73. Translational Regenerative Medicine Market: Company Product Type Footprint
    Table 74. Translational Regenerative Medicine Market: Company Product Application Footprint
    Table 75. Translational Regenerative Medicine New Market Entrants and Barriers to Market Entry
    Table 76. Translational Regenerative Medicine Mergers, Acquisition, Agreements, and Collaborations
    Table 77. Global Translational Regenerative Medicine Sales Quantity by Region (2018-2023) & (K Units)
    Table 78. Global Translational Regenerative Medicine Sales Quantity by Region (2024-2029) & (K Units)
    Table 79. Global Translational Regenerative Medicine Consumption Value by Region (2018-2023) & (USD Million)
    Table 80. Global Translational Regenerative Medicine Consumption Value by Region (2024-2029) & (USD Million)
    Table 81. Global Translational Regenerative Medicine Average Price by Region (2018-2023) & (USD/Unit)
    Table 82. Global Translational Regenerative Medicine Average Price by Region (2024-2029) & (USD/Unit)
    Table 83. Global Translational Regenerative Medicine Sales Quantity by Type (2018-2023) & (K Units)
    Table 84. Global Translational Regenerative Medicine Sales Quantity by Type (2024-2029) & (K Units)
    Table 85. Global Translational Regenerative Medicine Consumption Value by Type (2018-2023) & (USD Million)
    Table 86. Global Translational Regenerative Medicine Consumption Value by Type (2024-2029) & (USD Million)
    Table 87. Global Translational Regenerative Medicine Average Price by Type (2018-2023) & (USD/Unit)
    Table 88. Global Translational Regenerative Medicine Average Price by Type (2024-2029) & (USD/Unit)
    Table 89. Global Translational Regenerative Medicine Sales Quantity by Application (2018-2023) & (K Units)
    Table 90. Global Translational Regenerative Medicine Sales Quantity by Application (2024-2029) & (K Units)
    Table 91. Global Translational Regenerative Medicine Consumption Value by Application (2018-2023) & (USD Million)
    Table 92. Global Translational Regenerative Medicine Consumption Value by Application (2024-2029) & (USD Million)
    Table 93. Global Translational Regenerative Medicine Average Price by Application (2018-2023) & (USD/Unit)
    Table 94. Global Translational Regenerative Medicine Average Price by Application (2024-2029) & (USD/Unit)
    Table 95. North America Translational Regenerative Medicine Sales Quantity by Type (2018-2023) & (K Units)
    Table 96. North America Translational Regenerative Medicine Sales Quantity by Type (2024-2029) & (K Units)
    Table 97. North America Translational Regenerative Medicine Sales Quantity by Application (2018-2023) & (K Units)
    Table 98. North America Translational Regenerative Medicine Sales Quantity by Application (2024-2029) & (K Units)
    Table 99. North America Translational Regenerative Medicine Sales Quantity by Country (2018-2023) & (K Units)
    Table 100. North America Translational Regenerative Medicine Sales Quantity by Country (2024-2029) & (K Units)
    Table 101. North America Translational Regenerative Medicine Consumption Value by Country (2018-2023) & (USD Million)
    Table 102. North America Translational Regenerative Medicine Consumption Value by Country (2024-2029) & (USD Million)
    Table 103. Europe Translational Regenerative Medicine Sales Quantity by Type (2018-2023) & (K Units)
    Table 104. Europe Translational Regenerative Medicine Sales Quantity by Type (2024-2029) & (K Units)
    Table 105. Europe Translational Regenerative Medicine Sales Quantity by Application (2018-2023) & (K Units)
    Table 106. Europe Translational Regenerative Medicine Sales Quantity by Application (2024-2029) & (K Units)
    Table 107. Europe Translational Regenerative Medicine Sales Quantity by Country (2018-2023) & (K Units)
    Table 108. Europe Translational Regenerative Medicine Sales Quantity by Country (2024-2029) & (K Units)
    Table 109. Europe Translational Regenerative Medicine Consumption Value by Country (2018-2023) & (USD Million)
    Table 110. Europe Translational Regenerative Medicine Consumption Value by Country (2024-2029) & (USD Million)
    Table 111. Asia-Pacific Translational Regenerative Medicine Sales Quantity by Type (2018-2023) & (K Units)
    Table 112. Asia-Pacific Translational Regenerative Medicine Sales Quantity by Type (2024-2029) & (K Units)
    Table 113. Asia-Pacific Translational Regenerative Medicine Sales Quantity by Application (2018-2023) & (K Units)
    Table 114. Asia-Pacific Translational Regenerative Medicine Sales Quantity by Application (2024-2029) & (K Units)
    Table 115. Asia-Pacific Translational Regenerative Medicine Sales Quantity by Region (2018-2023) & (K Units)
    Table 116. Asia-Pacific Translational Regenerative Medicine Sales Quantity by Region (2024-2029) & (K Units)
    Table 117. Asia-Pacific Translational Regenerative Medicine Consumption Value by Region (2018-2023) & (USD Million)
    Table 118. Asia-Pacific Translational Regenerative Medicine Consumption Value by Region (2024-2029) & (USD Million)
    Table 119. South America Translational Regenerative Medicine Sales Quantity by Type (2018-2023) & (K Units)
    Table 120. South America Translational Regenerative Medicine Sales Quantity by Type (2024-2029) & (K Units)
    Table 121. South America Translational Regenerative Medicine Sales Quantity by Application (2018-2023) & (K Units)
    Table 122. South America Translational Regenerative Medicine Sales Quantity by Application (2024-2029) & (K Units)
    Table 123. South America Translational Regenerative Medicine Sales Quantity by Country (2018-2023) & (K Units)
    Table 124. South America Translational Regenerative Medicine Sales Quantity by Country (2024-2029) & (K Units)
    Table 125. South America Translational Regenerative Medicine Consumption Value by Country (2018-2023) & (USD Million)
    Table 126. South America Translational Regenerative Medicine Consumption Value by Country (2024-2029) & (USD Million)
    Table 127. Middle East & Africa Translational Regenerative Medicine Sales Quantity by Type (2018-2023) & (K Units)
    Table 128. Middle East & Africa Translational Regenerative Medicine Sales Quantity by Type (2024-2029) & (K Units)
    Table 129. Middle East & Africa Translational Regenerative Medicine Sales Quantity by Application (2018-2023) & (K Units)
    Table 130. Middle East & Africa Translational Regenerative Medicine Sales Quantity by Application (2024-2029) & (K Units)
    Table 131. Middle East & Africa Translational Regenerative Medicine Sales Quantity by Region (2018-2023) & (K Units)
    Table 132. Middle East & Africa Translational Regenerative Medicine Sales Quantity by Region (2024-2029) & (K Units)
    Table 133. Middle East & Africa Translational Regenerative Medicine Consumption Value by Region (2018-2023) & (USD Million)
    Table 134. Middle East & Africa Translational Regenerative Medicine Consumption Value by Region (2024-2029) & (USD Million)
    Table 135. Translational Regenerative Medicine Raw Material
    Table 136. Key Manufacturers of Translational Regenerative Medicine Raw Materials
    Table 137. Translational Regenerative Medicine Typical Distributors
    Table 138. Translational Regenerative Medicine Typical Customers
List of Figures
    Figure 1. Translational Regenerative Medicine Picture
    Figure 2. Global Translational Regenerative Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Translational Regenerative Medicine Consumption Value Market Share by Type in 2022
    Figure 4. Stem Cell Therapy Examples
    Figure 5. Tissue Engineering Examples
    Figure 6. Gene Therapy Examples
    Figure 7. Global Translational Regenerative Medicine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 8. Global Translational Regenerative Medicine Consumption Value Market Share by Application in 2022
    Figure 9. Tissue Engineering Therapy Examples
    Figure 10. Wound Healing Examples
    Figure 11. Cartilage Repair Examples
    Figure 12. Other Examples
    Figure 13. Global Translational Regenerative Medicine Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 14. Global Translational Regenerative Medicine Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 15. Global Translational Regenerative Medicine Sales Quantity (2018-2029) & (K Units)
    Figure 16. Global Translational Regenerative Medicine Average Price (2018-2029) & (USD/Unit)
    Figure 17. Global Translational Regenerative Medicine Sales Quantity Market Share by Manufacturer in 2022
    Figure 18. Global Translational Regenerative Medicine Consumption Value Market Share by Manufacturer in 2022
    Figure 19. Producer Shipments of Translational Regenerative Medicine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 20. Top 3 Translational Regenerative Medicine Manufacturer (Consumption Value) Market Share in 2022
    Figure 21. Top 6 Translational Regenerative Medicine Manufacturer (Consumption Value) Market Share in 2022
    Figure 22. Global Translational Regenerative Medicine Sales Quantity Market Share by Region (2018-2029)
    Figure 23. Global Translational Regenerative Medicine Consumption Value Market Share by Region (2018-2029)
    Figure 24. North America Translational Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
    Figure 25. Europe Translational Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
    Figure 26. Asia-Pacific Translational Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
    Figure 27. South America Translational Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
    Figure 28. Middle East & Africa Translational Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
    Figure 29. Global Translational Regenerative Medicine Sales Quantity Market Share by Type (2018-2029)
    Figure 30. Global Translational Regenerative Medicine Consumption Value Market Share by Type (2018-2029)
    Figure 31. Global Translational Regenerative Medicine Average Price by Type (2018-2029) & (USD/Unit)
    Figure 32. Global Translational Regenerative Medicine Sales Quantity Market Share by Application (2018-2029)
    Figure 33. Global Translational Regenerative Medicine Consumption Value Market Share by Application (2018-2029)
    Figure 34. Global Translational Regenerative Medicine Average Price by Application (2018-2029) & (USD/Unit)
    Figure 35. North America Translational Regenerative Medicine Sales Quantity Market Share by Type (2018-2029)
    Figure 36. North America Translational Regenerative Medicine Sales Quantity Market Share by Application (2018-2029)
    Figure 37. North America Translational Regenerative Medicine Sales Quantity Market Share by Country (2018-2029)
    Figure 38. North America Translational Regenerative Medicine Consumption Value Market Share by Country (2018-2029)
    Figure 39. United States Translational Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Canada Translational Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Mexico Translational Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 42. Europe Translational Regenerative Medicine Sales Quantity Market Share by Type (2018-2029)
    Figure 43. Europe Translational Regenerative Medicine Sales Quantity Market Share by Application (2018-2029)
    Figure 44. Europe Translational Regenerative Medicine Sales Quantity Market Share by Country (2018-2029)
    Figure 45. Europe Translational Regenerative Medicine Consumption Value Market Share by Country (2018-2029)
    Figure 46. Germany Translational Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. France Translational Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. United Kingdom Translational Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Russia Translational Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Italy Translational Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 51. Asia-Pacific Translational Regenerative Medicine Sales Quantity Market Share by Type (2018-2029)
    Figure 52. Asia-Pacific Translational Regenerative Medicine Sales Quantity Market Share by Application (2018-2029)
    Figure 53. Asia-Pacific Translational Regenerative Medicine Sales Quantity Market Share by Region (2018-2029)
    Figure 54. Asia-Pacific Translational Regenerative Medicine Consumption Value Market Share by Region (2018-2029)
    Figure 55. China Translational Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Japan Translational Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Korea Translational Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. India Translational Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. Southeast Asia Translational Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. Australia Translational Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 61. South America Translational Regenerative Medicine Sales Quantity Market Share by Type (2018-2029)
    Figure 62. South America Translational Regenerative Medicine Sales Quantity Market Share by Application (2018-2029)
    Figure 63. South America Translational Regenerative Medicine Sales Quantity Market Share by Country (2018-2029)
    Figure 64. South America Translational Regenerative Medicine Consumption Value Market Share by Country (2018-2029)
    Figure 65. Brazil Translational Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 66. Argentina Translational Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 67. Middle East & Africa Translational Regenerative Medicine Sales Quantity Market Share by Type (2018-2029)
    Figure 68. Middle East & Africa Translational Regenerative Medicine Sales Quantity Market Share by Application (2018-2029)
    Figure 69. Middle East & Africa Translational Regenerative Medicine Sales Quantity Market Share by Region (2018-2029)
    Figure 70. Middle East & Africa Translational Regenerative Medicine Consumption Value Market Share by Region (2018-2029)
    Figure 71. Turkey Translational Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Egypt Translational Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Saudi Arabia Translational Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. South Africa Translational Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 75. Translational Regenerative Medicine Market Drivers
    Figure 76. Translational Regenerative Medicine Market Restraints
    Figure 77. Translational Regenerative Medicine Market Trends
    Figure 78. Porters Five Forces Analysis
    Figure 79. Manufacturing Cost Structure Analysis of Translational Regenerative Medicine in 2022
    Figure 80. Manufacturing Process Analysis of Translational Regenerative Medicine
    Figure 81. Translational Regenerative Medicine Industrial Chain
    Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 83. Direct Channel Pros & Cons
    Figure 84. Indirect Channel Pros & Cons
    Figure 85. Methodology
    Figure 86. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Athersys
Avita Medical
AxoGen
MEDIPOST
NuVasive
Astellas Pharma
Organogenesis Holdings
Osiris Therapeutics
Pharmicell
Regenerys
Takeda Pharmaceutical
uniQure
Vericel

Related Reports

Global Translational Regenerative Medicine Supply, Demand and Key Producers, 2023-2029

Global Translational Regenerative Medicine Supply, Demand and Key Producers, 2023-2029

date 26 Mar 2023

date Medical Devices & Consumables

This report studies the global Translational Regenerative Medicine production, demand, key manufacturers, and key regions.

Global Translational Regenerative Medicine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Translational Regenerative Medicine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Translational Regenerative Medicine market size was valued at USD 12590 million in 2023 and is forecast to a readjusted size of USD 29460 million by 2030 with a CAGR of 12.9% during review period.

Product Tags

Translational Regenerative Medicine

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>